Loading organizations...
§ Private Profile · Pittsburgh, PA, USA
Generative AI platform that transcribes doctor-patient conversations into structured clinical notes for health systems, integrating with EHRs.
Abridge has raised $773.0M across 8 funding rounds.
Key people at Abridge.
Abridge was founded in 2018 by Shiv Rao (Co-Founder).
Abridge has raised $773.0M in total across 8 funding rounds.
San Francisco-based Abridge develops a generative artificial intelligence platform that automatically transcribes and summarizes doctor-patient conversations into structured clinical documentation. The business-to-business software-as-a-service company operates with a workforce of more than 200 employees and is currently deployed across over 100 United States health systems to reduce administrative burdens. Abridge integrates directly with electronic health record providers like Epic and serves major healthcare networks including Kaiser Permanente and UPMC, where its proprietary technology has processed over 6.3 million patient visits. Backed by prominent lead investors such as Lightspeed Venture Partners and IVP, the startup has raised $758 million in total funding, reaching a $5.3 billion valuation following a $300 million funding round in July 2025. The healthcare technology company was originally founded in 2018 by practicing cardiologist Shiv Rao alongside Sandeep Konam and Florian Metze.
Key people at Abridge.
Abridge is a Pittsburgh-based healthtech company founded in 2018 that builds an AI-powered platform to transform patient-clinician conversations into structured, real-time clinical notes integrated with electronic health records (EHRs) like Epic.[1][2][3][5] It serves clinicians, nurses, billing teams, and large healthcare systems such as Kaiser Permanente, Duke Health, Johns Hopkins Medicine, Mayo Clinic, UChicago Medicine, and Emory Healthcare, solving clinician burnout and administrative overload by automating documentation—reducing after-hours work by 86%, cognitive load by 78%, and improving professional fulfillment by 53%.[2][3][5][6] With $212.5 million raised, including a $150 million Series C in early 2024, Abridge has achieved rapid growth, deploying across dozens of systems, specialties, languages, and settings like emergency departments and nursing workflows.[2][5][6]
Abridge emerged in 2018 from a mission to power deeper understanding in healthcare through purpose-built AI, founded by a team blending practicing MDs, AI scientists, PhDs, engineers, and technologists.[1][4] Key leaders emphasize transforming patient-provider interactions with empathetic, cutting-edge tech; for instance, executives highlight the company's DNA in healthcare and technology to enhance millions of medical conversations annually.[4] Early traction built on proprietary data from over 1.5 million medical encounters, enabling real-time note generation and EHR integration, which fueled rapid scaling recognized by awards like Fierce Healthcare's Fierce 15 in 2024.[2] Pivotal moments include partnerships with Epic for emergency medicine and nursing tools, plus deployments at top systems like UPMC (its Pittsburgh roots) and nationwide expansion.[2][5][6]
Abridge rides the generative AI wave in healthcare, targeting documentation inefficiencies amid clinician shortages and burnout crises, with timing amplified by post-2023 AI adoption surges.[2][5] Market forces like EHR dominance (e.g., Epic partnerships) and regulatory pushes for AI accountability favor its auditable model, setting standards for responsible deployment across health systems.[1][2] It influences the ecosystem by scaling to tens of thousands of users, iterating via feedback, and pioneering expansions like nursing AI with Mayo Clinic—driving efficiency, patient engagement, and outcomes in a $4 trillion U.S. healthcare market increasingly open to AI.[2][5][6]
Abridge's trajectory points to dominance in ambient clinical AI, with next steps likely including broader nurse/ED tooling, multilingual global reach, and revenue innovations like point-of-conversation prior auth (announced August 2025).[5] Trends in AI regulation, value-based care, and clinician retention will propel it, potentially evolving from documentation leader to full conversation intelligence platform. As pioneers mapping AI to clinical truth, Abridge exemplifies how purpose-built tech restores focus to patient care in an overburdened system.[1][2]
Abridge was founded in 2018 by Shiv Rao (Co-Founder).
Abridge has raised $773.0M in total across 8 funding rounds.
Abridge's investors include Andreessen Horowitz, CVS Health, IVP, Lightspeed Venture Partners, Pillar VC, Spark Capital, Union Square Ventures, Elad Gil, Esther Dyson, Yoshua Bengio, Accel, Alkeon Capital.
Abridge has raised $773.0M across 8 funding rounds. Most recently, it raised $300.0M Series E in June 2025.